December 11, 2017 7:24 AM ET

Healthcare Equipment and Supplies

Company Overview of Armune BioScience, Inc.

Company Overview

Armune BioScience, Inc., a medical diagnostics company, develops and commercializes blood tests that leverage the warning signals produced by the body’s immune system in response to the onset of cancer. It researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that allow physicians and patients to make personalized treatment decisions for prognosis. The company offers APIFINY, a cancer specific non-PSA blood test that aids clinicians in the assessment of risk for the presence of prostate cancer by measuring specific biological markers that are associated with an immune system. Its APIFINY blood test is used by primary-care physicians, urologists, and o...

350 East Michigan Avenue

Suite 500

Kalamazoo, MI 49007

United States

Founded in 2007





Key Executives for Armune BioScience, Inc.

CEO, President & Director
Age: 49
Chief Financial Officer
Chief Operating Officer
Chief Medical Officer
Laboratory Director
Compensation as of Fiscal Year 2017.

Armune BioScience, Inc. Key Developments

Armune BioScience, Inc. Presents at 36th Annual Michigan Growth Capital Symposium, May-16-2017 02:20 PM

Armune BioScience, Inc. Presents at 36th Annual Michigan Growth Capital Symposium, May-16-2017 02:20 PM. Venue: Marriott Resort at Eagle Crest, 1275 S. Huron Street, Ypsilanti, MI 48197, United States.

Armune BioScience, Inc. Presents at Coulter Investment Forum, May-16-2017 01:10 PM

Armune BioScience, Inc. Presents at Coulter Investment Forum, May-16-2017 01:10 PM. Venue: Marriott Resort, ANN ARBOR, MI, United States.

Aeterna Zentaris Inc. Announces Exclusive Promotional Agreement with Armune BioScience, Inc

Aeterna Zentaris Inc. announced that it is expanding its promotion of APIFINY, the only cancer-specific, non-PSA blood test available to assess the risk for the presence of prostate cancer, into the important Florida market pursuant to its exclusive promotional agreement with Armune BioScience, Inc. The expansion into Florida follows Armune’s receipt of a clinical laboratory license from the State of Florida.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Private Placement
January 13, 2017

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Armune BioScience, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at